Pain Relief of Newborn Preterm Infants During Endotracheal Suctioning
PRPS
1 other identifier
interventional
43
1 country
1
Brief Summary
Evaluate the effectiveness of the use of a 24% sucrose solution for pain management of preterm infants during endotracheal suctioning.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_2 pain
Started Mar 2010
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2010
CompletedFirst Submitted
Initial submission to the registry
September 14, 2010
CompletedFirst Posted
Study publicly available on registry
September 15, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2011
CompletedApril 26, 2011
September 1, 2010
1.1 years
September 14, 2010
April 25, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
clinical pain score
The tool that will be used is PIPP = Premature Infant Pain Profile. This avaliation begins prior to suctioning until 30 seconds after suctioning. Each infant will be avaliated 2 times (with sucrose and with placebo). The 2 avaliations in the same day.
within the first twelve hours after clinical stabilization, the PIPP will be done.
Study Arms (2)
sucrose
ACTIVE COMPARATOR0,5 ml/kg of sucrose administered 2 minutes prior the procedure
sterile water
PLACEBO COMPARATOR0,5 ml/kg of sterile water administered 2 minutes prior the procedure
Interventions
oral sucrose solution, 24%, 0,5 ml/kg, 2 minutes before start the suctioning sterile water, 0,5 ml/kg, 2 minutes before start the suctioning
Eligibility Criteria
You may qualify if:
- preterm infants
- over 12 hours of life
- intubated
- clinically stable
- without use of analgesics or sedatives
You may not qualify if:
- preterms with congenital malformations
- preterms with genetic syndromes
- preterms with Apgar score at 5´\<7
- preterms with meningitis
- preterms with diagnosed of necrotizing enterocolitis Ouvir Ler foneticamente
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital Agamenon Magalhães, Hospital Barão de Lucena
Recife, Pernambuco, Brazil
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rita A Almeida, postgraduate
Universidade Federal de Pernambuco
- STUDY DIRECTOR
Sônia B Coutinho, Dr.
Universidade Federal de Pernambuco
- STUDY DIRECTOR
Pedro I Lira, Dr.
Universidade Federal de Pernambuco
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
September 14, 2010
First Posted
September 15, 2010
Study Start
March 1, 2010
Primary Completion
April 1, 2011
Study Completion
April 1, 2011
Last Updated
April 26, 2011
Record last verified: 2010-09